Gemtuzumab ozogamicin for the treatment of acute promyelocytic leukemia: mechanisms of action and resistance, safety and efficacy

By Breccia Massimo   Lo-Coco Francesco  

Expert Opinion on Biological Therapy, Vol. 11, Iss. 2, 2011-02 ,pp. : 225-234

Informa Healthcare

Access to resources Recommend Favorite

Gemtuzumab ozogamicin: an anti-CD33 immunoconjugate for the treatment of acute myeloid leukaemia

By Stasi Roberto  

Expert Opinion on Biological Therapy, Vol. 8, Iss. 4, 2008-04 ,pp. : 527-540

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukaemia in first relapse

By Sievers Eric L  

Expert Opinion on Biological Therapy, Vol. 1, Iss. 5, 2001-09 ,pp. : 893-901

Informa Healthcare

Access to resources Recommend Favorite

RACK1 promotes the proliferation of THP1 acute myeloid leukemia cells

By Zhang Dalin   Wang Qingyang   Zhu Ting   Cao Junxia   Zhang Xueying   Wang Jing   Wang Xiaoqian   Li Yan   Shen Beifen   Zhang Jiyan  

Molecular and Cellular Biochemistry, Vol. 384, Iss. 1-2, 2013-12 ,pp. : 197-202

Springer Publishing Company

Access to resources Recommend Favorite

Oxidative stress enhances granulocytic differentiation in HL 60 cells, an acute promyelocytic leukemia cell line

By Ogino Tetsuya   Ozaki Michitaka   Matsukawa Akihiro  

Free Radical Research, Vol. 44, Iss. 11, 2010-11 ,pp. : 1328-1337

Informa Healthcare

Access to resources Recommend Favorite